Notogen, Inc.

Canada

Back to Profile
1-5 of 5 for Notogen, Inc. Sort by
Query
Aggregations
Date
2023 1
2021 2
Before 2020 2
IPC Class
A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine 5
A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate 5
A61K 38/18 - Growth factorsGrowth regulators 5
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids 5
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin 5
See more
Status
Pending 1
Registered / In Force 4
Found results for  patents

1.

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

      
Application Number 17903910
Status Pending
Filing Date 2022-09-06
First Publication Date 2023-04-20
Owner
  • University Health Network (Canada)
  • Notogen, Inc. (Canada)
Inventor
  • Erwin, William Mark
  • Eek, Bjorn C. J.

Abstract

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

IPC Classes  ?

  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/08 - Solutions
  • C07K 14/495 - Transforming growth factor [TGF]
  • C07H 5/06 - Aminosugars
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • C08L 5/08 - ChitinChondroitin sulfateHyaluronic acidDerivatives thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • C07K 14/475 - Growth factorsGrowth regulators
  • C07H 3/02 - Monosaccharides
  • A61K 38/18 - Growth factorsGrowth regulators
  • A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

2.

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

      
Application Number 17358731
Grant Number 11471480
Status In Force
Filing Date 2021-06-25
First Publication Date 2021-11-18
Grant Date 2022-10-18
Owner
  • UNIVERSITY HEALTH NETWORK (Canada)
  • NOTOGEN, INC. (Canada)
Inventor
  • Erwin, William Mark
  • Eek, Bjorn C. J.

Abstract

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

IPC Classes  ?

  • A61K 38/18 - Growth factorsGrowth regulators
  • C07K 14/475 - Growth factorsGrowth regulators
  • C07K 14/495 - Transforming growth factor [TGF]
  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
  • A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
  • C07H 5/06 - Aminosugars
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/08 - Solutions
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • C08L 5/08 - ChitinChondroitin sulfateHyaluronic acidDerivatives thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • C07H 3/02 - Monosaccharides
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • C08L 1/28 - Alkyl ethers

3.

Compositions and methods for degenerative disc regeneration

      
Application Number 17358736
Grant Number 11491180
Status In Force
Filing Date 2021-06-25
First Publication Date 2021-10-14
Grant Date 2022-11-08
Owner
  • UNIVERSITY HEALTH NETWORK (Canada)
  • NOTOGEN. INC. (Canada)
Inventor
  • Erwin, William Mark
  • Eek, Bjorn C. J.

Abstract

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

IPC Classes  ?

  • A61K 38/18 - Growth factorsGrowth regulators
  • C07K 14/495 - Transforming growth factor [TGF]
  • C07K 14/475 - Growth factorsGrowth regulators
  • A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/08 - Solutions
  • C07H 5/06 - Aminosugars
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • C08L 5/08 - ChitinChondroitin sulfateHyaluronic acidDerivatives thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • C07H 3/02 - Monosaccharides
  • A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
  • C08L 1/28 - Alkyl ethers

4.

Compositions and methods for degenerative disc regeneration

      
Application Number 16525428
Grant Number 11141427
Status In Force
Filing Date 2019-07-29
First Publication Date 2019-11-21
Grant Date 2021-10-12
Owner NOTOGEN, INC. (Canada)
Inventor Erwin, William Mark

Abstract

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

IPC Classes  ?

  • A61K 38/18 - Growth factorsGrowth regulators
  • C07K 14/495 - Transforming growth factor [TGF]
  • C07K 14/475 - Growth factorsGrowth regulators
  • A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/08 - Solutions
  • C07H 5/06 - Aminosugars
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • C08L 5/08 - ChitinChondroitin sulfateHyaluronic acidDerivatives thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • C07H 3/02 - Monosaccharides
  • C08L 1/28 - Alkyl ethers

5.

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

      
Application Number 15737096
Grant Number 11141426
Status In Force
Filing Date 2016-11-04
First Publication Date 2018-06-21
Grant Date 2021-10-12
Owner NOTOGEN, INC. (Canada)
Inventor Erwin, William Mark

Abstract

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

IPC Classes  ?

  • A61K 38/18 - Growth factorsGrowth regulators
  • C07K 14/495 - Transforming growth factor [TGF]
  • C07K 14/475 - Growth factorsGrowth regulators
  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
  • C07H 5/06 - Aminosugars
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/08 - Solutions
  • C08L 5/08 - ChitinChondroitin sulfateHyaluronic acidDerivatives thereof
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • C07H 3/02 - Monosaccharides
  • A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • C08L 1/28 - Alkyl ethers